Australian Broker Call

Produced and copyrighted by at www.fnarena.com

March 31, 2020

Access Broker Call Report Archives here

COMPANIES DISCUSSED IN THIS ISSUE

Click on symbol for fast access.

The number next to the symbol represents the number of brokers covering it for this report -(if more than 1).

Last Updated: 05:00 PM

Your daily news report on the latest recommendation, valuation, forecast and opinion changes.

This report includes concise but limited reviews of research recently published by Stockbrokers, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end.

For more info about the different terms used by stockbrokers, as well as the different methodologies behind similar sounding ratings, download our guide HERE

Today's Upgrades and Downgrades
ANN - ANSELL Upgrade to Buy from Neutral Citi
Upgrade to Outperform from Neutral Credit Suisse
Upgrade to Hold from Lighten Ord Minnett
ASG - AUTOSPORTS GROUP Downgrade to Neutral from Outperform Macquarie
BXB - BRAMBLES Upgrade to Overweight from Equal-weight Morgan Stanley
CGF - CHALLENGER Upgrade to Buy from Neutral Citi
Upgrade to Hold from Sell Ord Minnett
CWN - CROWN RESORTS Upgrade to Buy from Neutral UBS
MQG - MACQUARIE GROUP Upgrade to Buy from Hold Ord Minnett
RAP - RESAPP HEALTH Upgrade to Spec Buy from Hold Morgans
SCG - SCENTRE GROUP Upgrade to Neutral from Sell UBS
SGF - SG FLEET Downgrade to Neutral from Outperform Macquarie
SGR - STAR ENTERTAINMENT Upgrade to Buy from Neutral UBS
WPL - WOODSIDE PETROLEUM Upgrade to Buy from Neutral UBS
ADH  ADAIRS LIMITED

Furniture & Renovation

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.91

Morgans rates ADH as Hold (3) -

Adairs has closed all its stores, stood down 90% of staff and is not paying rent. Online growth remains strong, the broker notes, generating positive cash flow. The broker believes the company has enough liquidity to keep creditors at bay.

It is unclear when Adairs might be able to restock, and the risk is this may impact on the critical Christmas period, the broker warns, even if stores reopen in coming months. Bank support may still be needed.

Despite having been sold down to extreme levels, the stock is still subject to retail uncertainty, hence the broker retains Hold. Target falls to $1.22 from $1.60.

Target price is $1.22 Current Price is $0.91 Difference: $0.31
If ADH meets the Morgans target it will return approximately 34% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY20:

Morgans forecasts a full year FY20 dividend of 0.00 cents and EPS of 13.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.00.

Forecast for FY21:

Morgans forecasts a full year FY21 dividend of 0.00 cents and EPS of 9.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.11.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

AHY  ASALEO CARE LIMITED

Household & Personal Products

More Research Tools In Stock Analysis - click HERE

Overnight Price: $1.01

Macquarie rates AHY as Neutral (3) -

Macquarie expects the current economic environment and social isolation will have a mixed impact on Asaleo Care.

Increased demand in the retail segment for personal products and contracts in the health and hygiene sectors will provide a boost.

Macquarie considers the defensive exposure of the stock attractive in the current environment and retains a Neutral rating.

The main uncertainty is the extent and severity of the economic slowdown. Target is reduced to $1.02 from $1.16.

Target price is $1.02 Current Price is $1.01 Difference: $0.01
If AHY meets the Macquarie target it will return approximately 1% (excluding dividends, fees and charges).

Current consensus price target is $1.19, suggesting upside of 17.8% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 4.00 cents and EPS of 6.60 cents.
At the last closing share price the estimated dividend yield is 3.96%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.30.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 6.7, implying annual growth of 63.4%.

Current consensus DPS estimate is 4.4, implying a prospective dividend yield of 4.4%.

Current consensus EPS estimate suggests the PER is 15.1.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 4.30 cents and EPS of 7.10 cents.
At the last closing share price the estimated dividend yield is 4.26%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.23.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 7.2, implying annual growth of 7.5%.

Current consensus DPS estimate is 4.9, implying a prospective dividend yield of 4.9%.

Current consensus EPS estimate suggests the PER is 14.0.

Market Sentiment: 0.7

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

AMC  AMCOR LIMITED

Paper & Packaging

More Research Tools In Stock Analysis - click HERE

Overnight Price: $13.02

Ord Minnett rates AMC as Accumulate (2) -

Amcor flags a benefit from the surge in demand for at-home food consumption and notes limited disruption to operations from the crisis so far.

The company believes it is well-positioned to manage the current environment. Ord Minnett continues to assess Amcor as a stand-out opportunity at current share price levels.

Accumulate rating maintained. Target is $17.

This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.

Target price is $17.00 Current Price is $13.02 Difference: $3.98
If AMC meets the Ord Minnett target it will return approximately 31% (excluding dividends, fees and charges).

Current consensus price target is $16.69, suggesting upside of 28.2% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Ord Minnett forecasts a full year FY20 EPS of 91.11 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.29.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 95.8, implying annual growth of N/A.

Current consensus DPS estimate is 71.6, implying a prospective dividend yield of 5.5%.

Current consensus EPS estimate suggests the PER is 13.6.

Forecast for FY21:

Ord Minnett forecasts a full year FY21 EPS of 99.62 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.07.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 110.9, implying annual growth of 15.8%.

Current consensus DPS estimate is 82.0, implying a prospective dividend yield of 6.3%.

Current consensus EPS estimate suggests the PER is 11.7.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.8

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

ANN  ANSELL LIMITED

Commercial Services & Supplies

More Research Tools In Stock Analysis - click HERE

Overnight Price: $27.16

Citi rates ANN as Upgrade to Buy from Neutral (1) -

The company has reiterated FY20 guidance. Citi observes there is little risk on the balance sheet, given significant liquidity and positive operating cash flow. Ansell also continues to buy back shares.

While the coronavirus has increased demand for surgical gloves and protective health equipment, it has had negative impact on the demand for industrial gloves, given manufacturing shut-downs.

The broker finds the net impact impossible to predict at this stage. Citi upgrades to Buy from Neutral. Target is raised to $34.50 from $32.00.

Target price is $34.50 Current Price is $27.16 Difference: $7.34
If ANN meets the Citi target it will return approximately 27% (excluding dividends, fees and charges).

Current consensus price target is $30.15, suggesting upside of 11.0% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Citi forecasts a full year FY20 dividend of 77.35 cents and EPS of 171.26 cents.
At the last closing share price the estimated dividend yield is 2.85%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.86.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 185.1, implying annual growth of N/A.

Current consensus DPS estimate is 81.1, implying a prospective dividend yield of 3.0%.

Current consensus EPS estimate suggests the PER is 14.7.

Forecast for FY21:

Citi forecasts a full year FY21 dividend of 84.97 cents and EPS of 185.32 cents.
At the last closing share price the estimated dividend yield is 3.13%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.66.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 197.4, implying annual growth of 6.6%.

Current consensus DPS estimate is 86.0, implying a prospective dividend yield of 3.2%.

Current consensus EPS estimate suggests the PER is 13.8.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Credit Suisse rates ANN as Upgrade to Outperform from Neutral (1) -

There is strong demand for single use gloves, surgical gloves and chemical protection. Credit Suisse estimates these divisions account for up to 45% of group sales and are likely to offset the weakness in industrial end-user demand.

Yet, the fixed cost nature of industrial items and the increased supply costs will likely limit the benefit.

The main tailwinds are in raw materials, including the fact Brent is down -60% since February and spot butadiene prices are down -15%. Credit Suisse upgrades to Outperform from Neutral. Target is $32.

Target price is $32.00 Current Price is $27.16 Difference: $4.84
If ANN meets the Credit Suisse target it will return approximately 18% (excluding dividends, fees and charges).

Current consensus price target is $30.15, suggesting upside of 11.0% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Credit Suisse forecasts a full year FY20 dividend of 69.95 cents and EPS of 165.54 cents.
At the last closing share price the estimated dividend yield is 2.58%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.41.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 185.1, implying annual growth of N/A.

Current consensus DPS estimate is 81.1, implying a prospective dividend yield of 3.0%.

Current consensus EPS estimate suggests the PER is 14.7.

Forecast for FY21:

Credit Suisse forecasts a full year FY21 dividend of 73.25 cents and EPS of 169.94 cents.
At the last closing share price the estimated dividend yield is 2.70%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.98.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 197.4, implying annual growth of 6.6%.

Current consensus DPS estimate is 86.0, implying a prospective dividend yield of 3.2%.

Current consensus EPS estimate suggests the PER is 13.8.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Morgan Stanley rates ANN as Overweight (1) -

Ansell has reiterated FY20 guidance, noting strong demand for its AlphaTec protective product as well as surgical gloves. This is offset by declining demand in some industrial products.

The company plans to provide guidance for FY21 at the FY20 result in August. Morgan Stanley welcomes the statement as it provides some confidence for the FY20 outlook, although envisages downside risk to FY21 expectations.

Overweight rating. Target is $28.90. Industry view is In-Line.

Target price is $28.90 Current Price is $27.16 Difference: $1.74
If ANN meets the Morgan Stanley target it will return approximately 6% (excluding dividends, fees and charges).

Current consensus price target is $30.15, suggesting upside of 11.0% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Morgan Stanley forecasts a full year FY20 dividend of 76.77 cents and EPS of 171.40 cents.
At the last closing share price the estimated dividend yield is 2.83%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.85.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 185.1, implying annual growth of N/A.

Current consensus DPS estimate is 81.1, implying a prospective dividend yield of 3.0%.

Current consensus EPS estimate suggests the PER is 14.7.

Forecast for FY21:

Morgan Stanley forecasts a full year FY21 dividend of 82.19 cents and EPS of 183.12 cents.
At the last closing share price the estimated dividend yield is 3.03%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.83.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 197.4, implying annual growth of 6.6%.

Current consensus DPS estimate is 86.0, implying a prospective dividend yield of 3.2%.

Current consensus EPS estimate suggests the PER is 13.8.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Ord Minnett rates ANN as Upgrade to Hold from Lighten (3) -

Sales have held up better than Ord Minnett expected, as coronavirus has caused extreme shortages in the supply of protective equipment in the health and hygiene sector.

The broker expects Ansell will obtain the lower end of its guidance range, even in the face of a substantial drop in demand for industrial safety gloves.

As FY20 forecasts are already in the guidance range, the broker makes no changes. Rating is upgraded to Hold from Lighten. Target is $28.

This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.

Target price is $28.00 Current Price is $27.16 Difference: $0.84
If ANN meets the Ord Minnett target it will return approximately 3% (excluding dividends, fees and charges).

Current consensus price target is $30.15, suggesting upside of 11.0% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Ord Minnett forecasts a full year FY20 EPS of 164.08 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.55.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 185.1, implying annual growth of N/A.

Current consensus DPS estimate is 81.1, implying a prospective dividend yield of 3.0%.

Current consensus EPS estimate suggests the PER is 14.7.

Forecast for FY21:

Ord Minnett forecasts a full year FY21 EPS of 175.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.45.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 197.4, implying annual growth of 6.6%.

Current consensus DPS estimate is 86.0, implying a prospective dividend yield of 3.2%.

Current consensus EPS estimate suggests the PER is 13.8.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

ASG  AUTOSPORTS GROUP LIMITED

Automobiles & Components

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.76

Macquarie rates ASG as Downgrade to Neutral from Outperform (3) -

Although Macquarie considers the luxury exposure of the business a positive, the company's earnings are not immune to the current crisis. New and used volumes are expected to decline.

The broker revises new vehicle sales estimates because of disruptions and expects a slowdown in back-end revenue under the current isolation directives.

Rating is downgraded to Neutral from Outperform and the target lowered to $1.10 from $1.75.

Target price is $1.10 Current Price is $0.76 Difference: $0.34
If ASG meets the Macquarie target it will return approximately 45% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 3.40 cents and EPS of 7.20 cents.
At the last closing share price the estimated dividend yield is 4.47%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.56.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 7.90 cents and EPS of 12.10 cents.
At the last closing share price the estimated dividend yield is 10.39%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 6.28.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

AUB  AUB GROUP LIMITED

Diversified Financials

More Research Tools In Stock Analysis - click HERE

Overnight Price: $9.61

Credit Suisse rates AUB as Outperform (1) -

The company has withdrawn FY20 guidance. Credit Suisse suspects this is an act of prudence rather than an indication that guidance will not be met.

The company will defer the interim dividend payment to September to preserve cash and maintain liquidity.

The MGA Whittles transaction will not proceed and the proposal will be reviewed at a later stage. Credit Suisse lowers FY20 estimates for net profit by -2%.

The broker does not envisage a need to raise equity and considers earnings relatively protected. Outperform maintained. Target is reduced to $12.60 from $13.15.

Target price is $12.60 Current Price is $9.61 Difference: $2.99
If AUB meets the Credit Suisse target it will return approximately 31% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY20:

Credit Suisse forecasts a full year FY20 dividend of 43.00 cents and EPS of 62.00 cents.
At the last closing share price the estimated dividend yield is 4.47%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.50.

Forecast for FY21:

Credit Suisse forecasts a full year FY21 dividend of 46.00 cents and EPS of 66.00 cents.
At the last closing share price the estimated dividend yield is 4.79%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.56.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Macquarie rates AUB as Outperform (1) -

Guidance has been withdrawn, the dividend delayed and the MGA Whittles deal cancelled. Gearing is largely unchanged, Macquarie observes.

Despite increased demand, the broker suspects the boost from premium funding is unlikely.

Still, the multi-sector exposure and diversified broker network are labelled "defensive" in the current environment and an Outperform rating is maintained. Target is reduced to $11.71 from $13.09.

Target price is $11.71 Current Price is $9.61 Difference: $2.1
If AUB meets the Macquarie target it will return approximately 22% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 14.50 cents and EPS of 63.10 cents.
At the last closing share price the estimated dividend yield is 1.51%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.23.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 32.00 cents and EPS of 63.10 cents.
At the last closing share price the estimated dividend yield is 3.33%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.23.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

BAP  BAPCOR LIMITED

Automobiles & Components

More Research Tools In Stock Analysis - click HERE

Overnight Price: $4.08

UBS rates BAP as Buy (1) -

Despite a firm performance in the third quarter, the company has suggested that escalating business closures and ongoing uncertainty have caused it to withdraw guidance.

A material drop in demand has been experienced as self-isolation protocols are implemented across Australasia. In response, the store network will be consolidated to a group of core sites and the cost base rationalised.

While there is short-term pressure on leverage covenants, UBS believes the company's debt syndicate is likely to provide some flexibility. Buy rating maintained. Target is reduced to $6.95 from $7.70.

Target price is $6.95 Current Price is $4.08 Difference: $2.87
If BAP meets the UBS target it will return approximately 70% (excluding dividends, fees and charges).

Current consensus price target is $7.16, suggesting upside of 75.5% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

UBS forecasts a full year FY20 dividend of 8.00 cents and EPS of 21.40 cents.
At the last closing share price the estimated dividend yield is 1.96%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.07.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 31.7, implying annual growth of -7.8%.

Current consensus DPS estimate is 15.0, implying a prospective dividend yield of 3.7%.

Current consensus EPS estimate suggests the PER is 12.9.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 12.00 cents and EPS of 25.80 cents.
At the last closing share price the estimated dividend yield is 2.94%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.81.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 35.7, implying annual growth of 12.6%.

Current consensus DPS estimate is 19.1, implying a prospective dividend yield of 4.7%.

Current consensus EPS estimate suggests the PER is 11.4.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

BHP  BHP GROUP

Bulks

More Research Tools In Stock Analysis - click HERE

Overnight Price: $28.64

Macquarie rates BHP as Outperform (1) -

Macquarie delays the development scenario for Scarborough by a year, in line with updated guidance from Woodside Petroleum ((WPL)).

Pushing out the likely approval timeline for core petroleum products has a modest impact on earnings estimates.

BHP Group has 10 projects within the petroleum business, the bulk of which Macquarie expects are at risk of delay.

Maintaining production in the Pilbara is critical to forecasts. Buoyant iron ore prices also underpin expected cash generation. Outperform maintained with target price reduced to $38 from $41.

Target price is $38.00 Current Price is $28.64 Difference: $9.36
If BHP meets the Macquarie target it will return approximately 33% (excluding dividends, fees and charges).

Current consensus price target is $37.79, suggesting upside of 32.0% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 193.38 cents and EPS of 289.48 cents.
At the last closing share price the estimated dividend yield is 6.75%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.89.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 313.1, implying annual growth of N/A.

Current consensus DPS estimate is 207.6, implying a prospective dividend yield of 7.2%.

Current consensus EPS estimate suggests the PER is 9.1.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 205.10 cents and EPS of 290.36 cents.
At the last closing share price the estimated dividend yield is 7.16%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.86.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 322.1, implying annual growth of 2.9%.

Current consensus DPS estimate is 218.3, implying a prospective dividend yield of 7.6%.

Current consensus EPS estimate suggests the PER is 8.9.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.6

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

BOQ  BANK OF QUEENSLAND LIMITED

Banks

More Research Tools In Stock Analysis - click HERE

Overnight Price: $4.98

Morgan Stanley rates BOQ as Equal-weight (3) -

Morgan Stanley believes there is downside risk to forecasts as well as management's medium-term targets. Bank of Queensland has withdrawn FY20 guidance.

The broker currently forecasts FY20 cash earnings to be down -15% and the half-year dividend down at $0.22. The broker understands the medium-term targets still stand but may be reviewed.

Equal-weight. Target is $6.10. Industry view is In-Line.

Target price is $6.10 Current Price is $4.98 Difference: $1.12
If BOQ meets the Morgan Stanley target it will return approximately 22% (excluding dividends, fees and charges).

Current consensus price target is $6.43, suggesting upside of 29.1% (ex-dividends)

The company's fiscal year ends in August.

Forecast for FY20:

Morgan Stanley forecasts a full year FY20 dividend of 44.00 cents and EPS of 62.00 cents.
At the last closing share price the estimated dividend yield is 8.84%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.03.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 63.6, implying annual growth of -20.1%.

Current consensus DPS estimate is 47.9, implying a prospective dividend yield of 9.6%.

Current consensus EPS estimate suggests the PER is 7.8.

Forecast for FY21:

Morgan Stanley forecasts a full year FY21 dividend of 44.00 cents and EPS of 55.00 cents.
At the last closing share price the estimated dividend yield is 8.84%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.05.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 59.9, implying annual growth of -5.8%.

Current consensus DPS estimate is 45.3, implying a prospective dividend yield of 9.1%.

Current consensus EPS estimate suggests the PER is 8.3.

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Morgans rates BOQ as Hold (3) -

Bank of Queensland has withdrawn guidance, and will no longer seek approval in relation to the 12-month profit test for the interim dividend. This signals to the broker the bank will now be more conservative with dividends, which the broker also expects for the majors.

Once RBA support has run its course, the broker suggests funding and operational risk for Bank of Queensland are greater than for the majors, and that the bank's transformation strategy may in part be put on hold. Hold rating retained, target falls to $5.00 from $7.60.

Target price is $5.00 Current Price is $4.98 Difference: $0.02
If BOQ meets the Morgans target it will return approximately 0% (excluding dividends, fees and charges).

Current consensus price target is $6.43, suggesting upside of 29.1% (ex-dividends)

The company's fiscal year ends in August.

Forecast for FY20:

Morgans forecasts a full year FY20 dividend of 45.00 cents and EPS of 64.00 cents.
At the last closing share price the estimated dividend yield is 9.04%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.78.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 63.6, implying annual growth of -20.1%.

Current consensus DPS estimate is 47.9, implying a prospective dividend yield of 9.6%.

Current consensus EPS estimate suggests the PER is 7.8.

Forecast for FY21:

Morgans forecasts a full year FY21 dividend of 37.00 cents and EPS of 49.00 cents.
At the last closing share price the estimated dividend yield is 7.43%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.16.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 59.9, implying annual growth of -5.8%.

Current consensus DPS estimate is 45.3, implying a prospective dividend yield of 9.1%.

Current consensus EPS estimate suggests the PER is 8.3.

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Ord Minnett rates BOQ as Hold (3) -

Bank of Queensland has withdrawn FY20 guidance. The bank will not seek approval from APRA for exemption to the 12-month profit test for its first half dividend, which Ord Minnett suggests is signalling downside risk to previous guidance.

Still, the broker considers this a sensible decision. While the bank is on a firm footing after a capital raising, Ord Minnett remains cautious, given the poor deposit franchise, exposure to wholesale funding markets and business lending. Hold rating and $7.90 target maintained.

This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.

Target price is $7.90 Current Price is $4.98 Difference: $2.92
If BOQ meets the Ord Minnett target it will return approximately 59% (excluding dividends, fees and charges).

Current consensus price target is $6.43, suggesting upside of 29.1% (ex-dividends)

The company's fiscal year ends in August.

Forecast for FY20:

Ord Minnett forecasts a full year FY20 dividend of 48.00 cents and EPS of 66.00 cents.
At the last closing share price the estimated dividend yield is 9.64%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.55.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 63.6, implying annual growth of -20.1%.

Current consensus DPS estimate is 47.9, implying a prospective dividend yield of 9.6%.

Current consensus EPS estimate suggests the PER is 7.8.

Forecast for FY21:

Ord Minnett forecasts a full year FY21 dividend of 48.00 cents and EPS of 64.00 cents.
At the last closing share price the estimated dividend yield is 9.64%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.78.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 59.9, implying annual growth of -5.8%.

Current consensus DPS estimate is 45.3, implying a prospective dividend yield of 9.1%.

Current consensus EPS estimate suggests the PER is 8.3.

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

BXB  BRAMBLES LIMITED

Transportation & Logistics

More Research Tools In Stock Analysis - click HERE

Overnight Price: $10.50

Morgan Stanley rates BXB as Upgrade to Overweight from Equal-weight (1) -

Morgan Stanley believes Brambles is well-positioned as it has largely defensive end markets and an ongoing buyback. The company derives 85% of its revenue from staples, which allows it to participate in the surge in supermarket traffic.

The main issue for the broker is the margin outlook, given a mix of increased volume, price momentum, increased variable operating costs and fractionalisation of overheads.

To date, FY20 guidance for mid single-digit revenue and operating profit growth remains in place.

While the stock has outperformed the market over the last three months this is not to the same extent as others that have participated in the "essentials" supply chain.

Hence, Morgan Stanley upgrades to Overweight from Equal-weight. Target is raised to $13.00 from $12.80. Industry view is In-Line.

Target price is $13.00 Current Price is $10.50 Difference: $2.5
If BXB meets the Morgan Stanley target it will return approximately 24% (excluding dividends, fees and charges).

Current consensus price target is $12.49, suggesting upside of 19.0% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Morgan Stanley forecasts a full year FY20 dividend of 26.37 cents and EPS of 48.35 cents.
At the last closing share price the estimated dividend yield is 2.51%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.72.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 54.7, implying annual growth of N/A.

Current consensus DPS estimate is 41.5, implying a prospective dividend yield of 4.0%.

Current consensus EPS estimate suggests the PER is 19.2.

Forecast for FY21:

Morgan Stanley forecasts a full year FY21 dividend of 32.23 cents and EPS of 58.60 cents.
At the last closing share price the estimated dividend yield is 3.07%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.92.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 69.0, implying annual growth of 26.1%.

Current consensus DPS estimate is 41.6, implying a prospective dividend yield of 4.0%.

Current consensus EPS estimate suggests the PER is 15.2.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.2

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CAR  CARSALES.COM LIMITED

Automobiles & Components

More Research Tools In Stock Analysis - click HERE

Overnight Price: $11.69

UBS rates CAR as Neutral (3) -

The company is waiving all dealer fees in April. UBS also factors in a worse outlook for May.

While the company's leads held up well during the GFC, this time there are additional considerations which indicate volumes could fare much worse in the short term.

As physical restrictions relax, UBS assumes used car volumes moderate to high single-digit percentage declines in FY21. Neutral rating maintained. Target is reduced to $12.50 from $15.65.

Target price is $12.50 Current Price is $11.69 Difference: $0.81
If CAR meets the UBS target it will return approximately 7% (excluding dividends, fees and charges).

Current consensus price target is $16.97, suggesting upside of 45.1% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

UBS forecasts a full year FY20 dividend of 22.00 cents and EPS of 45.00 cents.
At the last closing share price the estimated dividend yield is 1.88%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 25.98.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 55.2, implying annual growth of 57.7%.

Current consensus DPS estimate is 41.7, implying a prospective dividend yield of 3.6%.

Current consensus EPS estimate suggests the PER is 21.2.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 38.00 cents and EPS of 45.00 cents.
At the last closing share price the estimated dividend yield is 3.25%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 25.98.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 60.8, implying annual growth of 10.1%.

Current consensus DPS estimate is 48.4, implying a prospective dividend yield of 4.1%.

Current consensus EPS estimate suggests the PER is 19.2.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CGF  CHALLENGER LIMITED

Wealth Management & Investments

More Research Tools In Stock Analysis - click HERE

Overnight Price: $3.99

Citi rates CGF as Upgrade to Buy from Neutral (1) -

Citi observes the risks on the balance sheet have been significantly reduced as the business increases the defensiveness of its asset portfolio.

As the stock is sold off substantially, the broker envisages scope for it to rally a little and raises the rating to Buy from Neutral.

While Challenger has reiterated FY20 normalised pre-tax profit guidance of $500-550m, this is a wide range and the broker notes the changes only affect FY20 profit for 3-4 months.

The larger earnings impact is likely to be felt in FY21, but then only to the extent the cash is not been redeployed. Target is $5.45.

Target price is $5.45 Current Price is $3.99 Difference: $1.46
If CGF meets the Citi target it will return approximately 37% (excluding dividends, fees and charges).

Current consensus price target is $5.68, suggesting upside of 42.4% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Citi forecasts a full year FY20 dividend of 35.50 cents and EPS of minus 9.80 cents.
At the last closing share price the estimated dividend yield is 8.90%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 40.71.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 42.9, implying annual growth of -15.7%.

Current consensus DPS estimate is 35.3, implying a prospective dividend yield of 8.8%.

Current consensus EPS estimate suggests the PER is 9.3.

Forecast for FY21:

Citi forecasts a full year FY21 dividend of 35.50 cents and EPS of 48.90 cents.
At the last closing share price the estimated dividend yield is 8.90%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.16.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 50.7, implying annual growth of 18.2%.

Current consensus DPS estimate is 32.4, implying a prospective dividend yield of 8.1%.

Current consensus EPS estimate suggests the PER is 7.9.

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Credit Suisse rates CGF as Neutral (3) -

The company has announced its capital position at the end of March amid a de-risking of its investment portfolio. Credit Suisse calculates investment experience losses, not disclosed, represent around 6.5% of the investment assets.

The broker assesses Challenger could withstand a further step down in investment markets similar to what has already been seen in March. Given the strength of its position, an equity raising is considered unlikely.

Neutral rating maintained. Target is reduced to $4.25 from $5.40.

Target price is $4.25 Current Price is $3.99 Difference: $0.26
If CGF meets the Credit Suisse target it will return approximately 7% (excluding dividends, fees and charges).

Current consensus price target is $5.68, suggesting upside of 42.4% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Credit Suisse forecasts a full year FY20 dividend of 35.00 cents and EPS of 49.00 cents.
At the last closing share price the estimated dividend yield is 8.77%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.14.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 42.9, implying annual growth of -15.7%.

Current consensus DPS estimate is 35.3, implying a prospective dividend yield of 8.8%.

Current consensus EPS estimate suggests the PER is 9.3.

Forecast for FY21:

Credit Suisse forecasts a full year FY21 dividend of 28.00 cents and EPS of 44.00 cents.
At the last closing share price the estimated dividend yield is 7.02%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.07.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 50.7, implying annual growth of 18.2%.

Current consensus DPS estimate is 32.4, implying a prospective dividend yield of 8.1%.

Current consensus EPS estimate suggests the PER is 7.9.

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Morgan Stanley rates CGF as Equal-weight (3) -

Challenger has materially de-risked its life asset allocation, Morgan Stanley observes. If it maintains this defensive allocation in FY21, net profit is likely to be reduced by -10-15%.

However, the broker considers this unlikely and expects Challenger will take advantage of wider credit spreads and any market dislocation to improve returns on investments.

Equal-weight and $8.60 target retained. Industry view: in Line.

Target price is $8.60 Current Price is $3.99 Difference: $4.61
If CGF meets the Morgan Stanley target it will return approximately 116% (excluding dividends, fees and charges).

Current consensus price target is $5.68, suggesting upside of 42.4% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Morgan Stanley forecasts a full year FY20 EPS of 53.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.53.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 42.9, implying annual growth of -15.7%.

Current consensus DPS estimate is 35.3, implying a prospective dividend yield of 8.8%.

Current consensus EPS estimate suggests the PER is 9.3.

Forecast for FY21:

Morgan Stanley forecasts a full year FY21 EPS of 53.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.53.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 50.7, implying annual growth of 18.2%.

Current consensus DPS estimate is 32.4, implying a prospective dividend yield of 8.1%.

Current consensus EPS estimate suggests the PER is 7.9.

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Ord Minnett rates CGF as Upgrade to Hold from Sell (3) -

Challenger has updated the market on the extent of its de-risking. The capital position has improved significantly yet Ord Minnett still has reservations.

There is still downside risk on property and sub investment-grade fixed income, suggest the analysts.

The broker considers the return on equity very low for the risks the business takes, suspecting in the short term dividends on assets may be reduced.

Rating is upgraded to Hold from Sell and the target lowered to $4.00 from $4.70.

This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.

Target price is $4.00 Current Price is $3.99 Difference: $0.01
If CGF meets the Ord Minnett target it will return approximately 0% (excluding dividends, fees and charges).

Current consensus price target is $5.68, suggesting upside of 42.4% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Ord Minnett forecasts a full year FY20 EPS of 52.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.67.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 42.9, implying annual growth of -15.7%.

Current consensus DPS estimate is 35.3, implying a prospective dividend yield of 8.8%.

Current consensus EPS estimate suggests the PER is 9.3.

Forecast for FY21:

Ord Minnett forecasts a full year FY21 EPS of 47.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.49.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 50.7, implying annual growth of 18.2%.

Current consensus DPS estimate is 32.4, implying a prospective dividend yield of 8.1%.

Current consensus EPS estimate suggests the PER is 7.9.

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


UBS rates CGF as Neutral (3) -

Despite significant asset mark-to-market losses, regulatory capital coverage for the life company is broadly in line with first half levels, given the actions taken to reduce asset risk. UBS believes the actions are necessary and sensible.

The company also retains additional capacity to manage ongoing balance sheet risks.

However, while FY20 net profit guidance is unchanged, reduced asset risk could mean life margins declined by more than -20% in the outer years, the broker points out. Neutral rating and $5.65 target maintained.

Target price is $5.65 Current Price is $3.99 Difference: $1.66
If CGF meets the UBS target it will return approximately 42% (excluding dividends, fees and charges).

Current consensus price target is $5.68, suggesting upside of 42.4% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

UBS forecasts a full year FY20 dividend of 35.00 cents and EPS of 52.00 cents.
At the last closing share price the estimated dividend yield is 8.77%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.67.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 42.9, implying annual growth of -15.7%.

Current consensus DPS estimate is 35.3, implying a prospective dividend yield of 8.8%.

Current consensus EPS estimate suggests the PER is 9.3.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 31.00 cents and EPS of 49.00 cents.
At the last closing share price the estimated dividend yield is 7.77%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.14.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 50.7, implying annual growth of 18.2%.

Current consensus DPS estimate is 32.4, implying a prospective dividend yield of 8.1%.

Current consensus EPS estimate suggests the PER is 7.9.

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CKF  COLLINS FOODS LIMITED

Food, Beverages & Tobacco

More Research Tools In Stock Analysis - click HERE

Overnight Price: $5.43

Morgans rates CKF as Add (1) -

Collins Foods had been seeing a continuation of recent sales trends up to the beginning of March, but KFC Australia sales fell -8% last week, which is a bit more than expected, while KFC Europe is down materially as was anticipated, the broker notes. The broker nevertheless expects sales to bounce back quickly in time.

The balance sheet is strong. The stock has fallen significantly along with all consumer-facing names and the broker sees reasonable risk/reward for patient investors. Add retained, target falls to $7.06 from $8.29.

Target price is $7.06 Current Price is $5.43 Difference: $1.63
If CKF meets the Morgans target it will return approximately 30% (excluding dividends, fees and charges).

The company's fiscal year ends in May.

Forecast for FY20:

Morgans forecasts a full year FY20 dividend of 10.00 cents and EPS of 37.00 cents.
At the last closing share price the estimated dividend yield is 1.84%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.68.

Forecast for FY21:

Morgans forecasts a full year FY21 dividend of 12.00 cents and EPS of 40.00 cents.
At the last closing share price the estimated dividend yield is 2.21%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.58.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CRN  CORONADO GLOBAL RESOURCES

Coal

More Research Tools In Stock Analysis - click HERE

Overnight Price: $1.13

Credit Suisse rates CRN as Outperform (1) -

The company has temporarily closed all US operations. As steel producers respond to softness in end markets the impact is now moving upstream to producers, Credit Suisse points out.

There is little visibility regarding how long operations will be closed. The broker considers the company fortunate to have a key contributor to production unaffected to date, with 750,000t of stockpiles in the US to assist cash flow.

Credit Suisse adjusts 2020 dividend expectations to a 60% pay-out, the lower end of the policy range, given management is likely to be conservative in the current environment. Outperform rating maintained. Target is $3.50.

Target price is $3.50 Current Price is $1.13 Difference: $2.37
If CRN meets the Credit Suisse target it will return approximately 210% (excluding dividends, fees and charges).

Current consensus price target is $2.68, suggesting upside of 137.5% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

Credit Suisse forecasts a full year FY20 dividend of 11.87 cents and EPS of 20.42 cents.
At the last closing share price the estimated dividend yield is 10.50%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 5.53.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 23.5, implying annual growth of N/A.

Current consensus DPS estimate is 13.9, implying a prospective dividend yield of 12.3%.

Current consensus EPS estimate suggests the PER is 4.8.

Forecast for FY21:

Credit Suisse forecasts a full year FY21 dividend of 13.71 cents and EPS of 28.08 cents.
At the last closing share price the estimated dividend yield is 12.13%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 4.02.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 32.6, implying annual growth of 38.7%.

Current consensus DPS estimate is 18.1, implying a prospective dividend yield of 16.0%.

Current consensus EPS estimate suggests the PER is 3.5.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.7

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CWN  CROWN RESORTS LIMITED

Gaming

More Research Tools In Stock Analysis - click HERE

Overnight Price: $7.55

UBS rates CWN as Upgrade to Buy from Neutral (1) -

UBS suggests the market is discounting the longer-term outlook for Crown Resorts. The broker estimates cash burn of -$40m per month during the period the casinos are shut down.

This provides significant flexibility against a cash balance of around $850m. Nevertheless, the broker assumes construction of Crown Sydney slows down.

Liquidity and gearing should not be an issue after the re-opening, if the company can collect on its estimated $800m of apartment sales.

The main downside risk is the NSW public casino inquiry, which has been postponed. Rating is upgraded to Buy from Neutral and the target reduced to $9.15 from $11.40.

Target price is $9.15 Current Price is $7.55 Difference: $1.6
If CWN meets the UBS target it will return approximately 21% (excluding dividends, fees and charges).

Current consensus price target is $9.25, suggesting upside of 22.5% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

UBS forecasts a full year FY20 dividend of 30.00 cents and EPS of 18.00 cents.
At the last closing share price the estimated dividend yield is 3.97%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 41.94.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 26.8, implying annual growth of -54.6%.

Current consensus DPS estimate is 40.0, implying a prospective dividend yield of 5.3%.

Current consensus EPS estimate suggests the PER is 28.2.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 0.00 cents and EPS of 20.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 37.75.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 31.3, implying annual growth of 16.8%.

Current consensus DPS estimate is 20.0, implying a prospective dividend yield of 2.6%.

Current consensus EPS estimate suggests the PER is 24.1.

Market Sentiment: 0.7

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

FCL  FINEOS CORPORATION HOLDINGS PLC

Cloud services

More Research Tools In Stock Analysis - click HERE

Overnight Price: $2.70

Macquarie rates FCL as Outperform (1) -

Macquarie reviews the risk to services revenue in light of the current uncertainty. Despite recent contract wins and upgraded revenue guidance, there is a risk new contracts are delayed or the service business slows.

The broker retains an Outperform rating and lowers the target to $3.48 from $4.30.

Target price is $3.48 Current Price is $2.70 Difference: $0.78
If FCL meets the Macquarie target it will return approximately 29% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 0.00 cents and EPS of 0.49 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 552.15.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 0.00 cents and EPS of 1.47 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 184.17.

This company reports in EUR. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

FMG  FORTESCUE METALS GROUP LTD

Iron Ore

More Research Tools In Stock Analysis - click HERE

Overnight Price: $9.94

Macquarie rates FMG as Outperform (1) -

The company has extended rosters for fly-in, fly-out (FIFO) workers that are expected to reduce the movement of people to site by -40%.

Production guidance is unchanged and, Macquarie notes, with 95% of the workforce based in Western Australia, further travel restrictions are unlikely to affect operations.

The broker assesses upgrade momentum is strong with the spot iron ore price scenario generating an increase of 30% in FY21 earnings and 130% in FY22.

Outperform retained. Target is raised to $13.70 from $12.40.

Target price is $13.70 Current Price is $9.94 Difference: $3.76
If FMG meets the Macquarie target it will return approximately 38% (excluding dividends, fees and charges).

Current consensus price target is $10.24, suggesting upside of 3.0% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 144.45 cents and EPS of 214.18 cents.
At the last closing share price the estimated dividend yield is 14.53%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 4.64.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 221.6, implying annual growth of N/A.

Current consensus DPS estimate is 232.1, implying a prospective dividend yield of 23.4%.

Current consensus EPS estimate suggests the PER is 4.5.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 113.39 cents and EPS of 162.03 cents.
At the last closing share price the estimated dividend yield is 11.41%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 6.13.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 151.4, implying annual growth of -31.7%.

Current consensus DPS estimate is 204.5, implying a prospective dividend yield of 20.6%.

Current consensus EPS estimate suggests the PER is 6.6.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

GNX  GENEX POWER LIMITED

EV, Solar & Batteries

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.15

Morgans rates GNX as Add (1) -

Genex Power has announced a 30-year offtake agreement with Energy Australia for the Kidston Hydro project. The project now needs final approval from the Northern Australian Infrastructure Facility and the Queensland government.

Genex still needs to sell a 50% stake to a JV partner, the broker notes, to limit required equity support. Target rises to 36c from 26c, Speculative Buy retained.

Target price is $0.36 Current Price is $0.15 Difference: $0.21
If GNX meets the Morgans target it will return approximately 140% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY20:

Morgans forecasts a full year FY20 dividend of 0.00 cents and EPS of 0.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 50.00.

Forecast for FY21:

Morgans forecasts a full year FY21 dividend of 0.00 cents and EPS of 0.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 37.50.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

GTN  GTN LIMITED

Print, Radio & TV

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.49

Macquarie rates GTN as Neutral (3) -

The company has advised that disruptions from coronavirus mean operating earnings will be more than -10% below consensus estimates.

Macquarie finds the impact difficult to quantify because of the unknown duration and severity of restrictions and associated reductions in advertising expenditure.

The company is, however, highly leveraged to an advertising expenditure recovery. Neutral maintained. Target is reduced to $0.47 from $0.74.

Target price is $0.47 Current Price is $0.49 Difference: minus $0.02 (current price is over target).
If GTN meets the Macquarie target it will return approximately minus 4% (excluding dividends, fees and charges - negative figures indicate an expected loss).

The company's fiscal year ends in June.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 1.40 cents and EPS of 5.00 cents.
At the last closing share price the estimated dividend yield is 2.86%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.80.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 3.40 cents and EPS of 5.70 cents.
At the last closing share price the estimated dividend yield is 6.94%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.60.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

IAG  INSURANCE AUSTRALIA GROUP LIMITED

Insurance

More Research Tools In Stock Analysis - click HERE

Overnight Price: $6.09

Citi rates IAG as Buy (1) -

Citi reduces estimates for earnings per share in FY20 by -28%. This reflects the impact of marking to market.

Insurance Australia Group has reiterated FY20 margin guidance and Citi suspects the current environment may be more favourable than detrimental to earnings.

The broker expects both motor and home claims frequency to drop but wonders whether it will be easy for the company to continue with premium rate rises in both personal and commercial lines in the current environment.

Buy rating and $7.70 target maintained.

Target price is $7.70 Current Price is $6.09 Difference: $1.61
If IAG meets the Citi target it will return approximately 26% (excluding dividends, fees and charges).

Current consensus price target is $7.06, suggesting upside of 15.9% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Citi forecasts a full year FY20 dividend of 25.00 cents and EPS of 21.30 cents.
At the last closing share price the estimated dividend yield is 4.11%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 28.59.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 30.2, implying annual growth of -19.4%.

Current consensus DPS estimate is 22.8, implying a prospective dividend yield of 3.7%.

Current consensus EPS estimate suggests the PER is 20.2.

Forecast for FY21:

Citi forecasts a full year FY21 dividend of 32.00 cents and EPS of 36.20 cents.
At the last closing share price the estimated dividend yield is 5.25%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.82.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 37.9, implying annual growth of 25.5%.

Current consensus DPS estimate is 30.7, implying a prospective dividend yield of 5.0%.

Current consensus EPS estimate suggests the PER is 16.1.

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Morgan Stanley rates IAG as Equal-weight (3) -

Insurance Australia Group has reiterated FY20 guidance for low single-digit growth in gross written premium and margin of 12.5-14.5%. Morgan Stanley observes the business is well-placed for capital.

Underwriting profit is also expected to benefit from lower motor and CTP claims. The company is offering up to 6 months deferral of premium payments for small-medium enterprises in hardship and full refunds for some policy cancellations.

Equal-weight rating. Target is $7.90. Industry view: In Line.

Target price is $7.90 Current Price is $6.09 Difference: $1.81
If IAG meets the Morgan Stanley target it will return approximately 30% (excluding dividends, fees and charges).

Current consensus price target is $7.06, suggesting upside of 15.9% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Morgan Stanley forecasts a full year FY20 dividend of 26.00 cents and EPS of 37.00 cents.
At the last closing share price the estimated dividend yield is 4.27%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.46.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 30.2, implying annual growth of -19.4%.

Current consensus DPS estimate is 22.8, implying a prospective dividend yield of 3.7%.

Current consensus EPS estimate suggests the PER is 20.2.

Forecast for FY21:

Morgan Stanley forecasts a full year FY21 dividend of 32.00 cents and EPS of 37.00 cents.
At the last closing share price the estimated dividend yield is 5.25%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.46.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 37.9, implying annual growth of 25.5%.

Current consensus DPS estimate is 30.7, implying a prospective dividend yield of 5.0%.

Current consensus EPS estimate suggests the PER is 16.1.

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


UBS rates IAG as Neutral (3) -

The company has updated on measures being taken during the current crisis. All up, UBS assesses capacity for capital management has been reduced given the marking-to-market losses and catastrophe claims.

The measures specifically surrounding coronavirus include up to a six-month deferral of premiums for those small-medium enterprises experiencing hardship.

With the sale of SBI General now complete, the company will record a net profit on the sale of $310m in FY20, boosting regulatory capital by $450m. Neutral rating and $6.65 target maintained.

Target price is $6.65 Current Price is $6.09 Difference: $0.56
If IAG meets the UBS target it will return approximately 9% (excluding dividends, fees and charges).

Current consensus price target is $7.06, suggesting upside of 15.9% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

UBS forecasts a full year FY20 dividend of 24.00 cents and EPS of 31.00 cents.
At the last closing share price the estimated dividend yield is 3.94%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.65.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 30.2, implying annual growth of -19.4%.

Current consensus DPS estimate is 22.8, implying a prospective dividend yield of 3.7%.

Current consensus EPS estimate suggests the PER is 20.2.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 31.00 cents and EPS of 39.00 cents.
At the last closing share price the estimated dividend yield is 5.09%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.62.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 37.9, implying annual growth of 25.5%.

Current consensus DPS estimate is 30.7, implying a prospective dividend yield of 5.0%.

Current consensus EPS estimate suggests the PER is 16.1.

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

IVC  INVOCARE LIMITED

Consumer Products & Services

More Research Tools In Stock Analysis - click HERE

Overnight Price: $10.51

Morgans rates IVC as Add (1) -

While funerals will continue to go ahead as an essential service, social gathering restrictions are limiting InvoCare's capacity to offer a full range of services, the broker notes. The broker estimates revenue per funeral to be -20-25% lower than usual.

The broker nevertheless sees a chance for longer term investors to step in to a highly defensive business offering a stable earnings stream. Add retained, target falls to $12.16 from $15.87.

Target price is $12.16 Current Price is $10.51 Difference: $1.65
If IVC meets the Morgans target it will return approximately 16% (excluding dividends, fees and charges).

Current consensus price target is $13.62, suggesting upside of 29.6% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

Morgans forecasts a full year FY20 dividend of 37.00 cents and EPS of 45.00 cents.
At the last closing share price the estimated dividend yield is 3.52%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 23.36.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 52.0, implying annual growth of -6.8%.

Current consensus DPS estimate is 40.5, implying a prospective dividend yield of 3.9%.

Current consensus EPS estimate suggests the PER is 20.2.

Forecast for FY21:

Morgans forecasts a full year FY21 dividend of 45.00 cents and EPS of 54.00 cents.
At the last closing share price the estimated dividend yield is 4.28%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.46.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 58.9, implying annual growth of 13.3%.

Current consensus DPS estimate is 46.4, implying a prospective dividend yield of 4.4%.

Current consensus EPS estimate suggests the PER is 17.8.

Market Sentiment: 0.2

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

MFG  MAGELLAN FINANCIAL GROUP LIMITED

Wealth Management & Investments

More Research Tools In Stock Analysis - click HERE

Overnight Price: $43.12

Morgans rates MFG as Hold (3) -

The broker has marked to current equity market valuations for Magellan Financial. Magellan is proving its resilience at this time, the broker notes, with an estimated 900 basis points of outperformance in the Global Fund this quarter.

The stock is now back to reasonable valuation on a medium term view, the broker suggests. The broker has not yet made recommendation changes ahead of the potential for more volatility. Target falls to $45.32 from $65.60, Hold retained.

Target price is $45.32 Current Price is $43.12 Difference: $2.2
If MFG meets the Morgans target it will return approximately 5% (excluding dividends, fees and charges).

Current consensus price target is $48.58, suggesting upside of 12.7% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Morgans forecasts a full year FY20 dividend of 205.00 cents and EPS of 222.00 cents.
At the last closing share price the estimated dividend yield is 4.75%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.42.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 232.9, implying annual growth of 9.3%.

Current consensus DPS estimate is 211.5, implying a prospective dividend yield of 4.9%.

Current consensus EPS estimate suggests the PER is 18.5.

Forecast for FY21:

Morgans forecasts a full year FY21 dividend of 203.00 cents and EPS of 220.00 cents.
At the last closing share price the estimated dividend yield is 4.71%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.60.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 240.4, implying annual growth of 3.2%.

Current consensus DPS estimate is 221.3, implying a prospective dividend yield of 5.1%.

Current consensus EPS estimate suggests the PER is 17.9.

Market Sentiment: -0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

MGX  MOUNT GIBSON IRON LIMITED

Iron Ore

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.68

Macquarie rates MGX as Outperform (1) -

Koolan Island shipments in the third quarter were well below forecasts. Mount Gibson has withdrawn FY20 production and cost guidance as a result of increased travel restrictions.

Macquarie reduces FY20 shipment forecasts from Koolan Island by -16%. FY21 forecasts are largely unchanged. Outperform rating maintained. Target is reduced to $1.00 from $1.10.

Target price is $1.00 Current Price is $0.68 Difference: $0.32
If MGX meets the Macquarie target it will return approximately 47% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 3.00 cents and EPS of 9.20 cents.
At the last closing share price the estimated dividend yield is 4.41%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.39.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 5.00 cents and EPS of 15.50 cents.
At the last closing share price the estimated dividend yield is 7.35%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 4.39.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

MP1  MEGAPORT LIMITED

Cloud services

More Research Tools In Stock Analysis - click HERE

Overnight Price: $9.67

Morgans rates MP1 as Add (1) -

Megaport is benefiting from global disruption, as existing and new customers consume more of the company's cloud service, remote working and other activities on a dedicated link, the broker reports.

The balance sheet is strong, and in a case of fortunate timing, Megaport put half its cash in USD a month ago to cover USD costs.

60% of the company's staff is already worked from home, moving to 100% provided few issues. The broker retains Add and a $12.94 target.

Target price is $12.94 Current Price is $9.67 Difference: $3.27
If MP1 meets the Morgans target it will return approximately 34% (excluding dividends, fees and charges).

Current consensus price target is $11.93, suggesting upside of 23.4% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Morgans forecasts a full year FY20 dividend of 0.00 cents and EPS of minus 26.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 37.19.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -24.4, implying annual growth of N/A.

Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.

Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY21:

Morgans forecasts a full year FY21 dividend of 0.00 cents and EPS of minus 21.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 46.05.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -16.8, implying annual growth of N/A.

Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.

Current consensus EPS estimate suggests the PER is N/A.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

MPL  MEDIBANK PRIVATE LIMITED

Insurance

More Research Tools In Stock Analysis - click HERE

Overnight Price: $2.63

Morgans rates MPL as Hold (3) -

Both Medibank Private and nib Holdings have announced they will suspend their approved 2020 premium rate increases for six months. Both will see large claims reductions, the broker notes, as elective surgery and a raft of other non-essential services are put on hold.

In terms of virus-related claims, Medibank has said these claims will be returned to customers while nib is looking forward to a resultant uplift to margins.

The broker has cut forecast earnings and lowered its Medibank target to $2.97 from $3.07. Hold retained, as while both insurers are relatively positioned better opportunities lie elsewhere in the sector, suggests the broker.

Target price is $2.97 Current Price is $2.63 Difference: $0.34
If MPL meets the Morgans target it will return approximately 13% (excluding dividends, fees and charges).

Current consensus price target is $2.87, suggesting upside of 9.3% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Morgans forecasts a full year FY20 dividend of 14.10 cents and EPS of 13.50 cents.
At the last closing share price the estimated dividend yield is 5.36%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.48.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 14.4, implying annual growth of -13.8%.

Current consensus DPS estimate is 12.7, implying a prospective dividend yield of 4.8%.

Current consensus EPS estimate suggests the PER is 18.3.

Forecast for FY21:

Morgans forecasts a full year FY21 dividend of 13.90 cents and EPS of 14.40 cents.
At the last closing share price the estimated dividend yield is 5.29%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.26.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 14.5, implying annual growth of 0.7%.

Current consensus DPS estimate is 12.6, implying a prospective dividend yield of 4.8%.

Current consensus EPS estimate suggests the PER is 18.1.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

MQG  MACQUARIE GROUP LIMITED

Wealth Management & Investments

More Research Tools In Stock Analysis - click HERE

Overnight Price: $85.73

Ord Minnett rates MQG as Upgrade to Buy from Hold (1) -

Ord Minnett suggests the stock has now overshot fundamentals, pointing out the market was slow to factor in the downside risks from the coronavirus outbreak.

Ord Minnett makes further reductions to forecasts but considers the -40% drop in the share price from the February peak presents a strong buying opportunity.

While further risks cannot be dismissed the extraordinary support being offered by governments is expected to ensure the coming recession is shortened.

Rating is upgraded to Buy from Hold. Target is lowered to $112 from $132.

This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.

Target price is $112.00 Current Price is $85.73 Difference: $26.27
If MQG meets the Ord Minnett target it will return approximately 31% (excluding dividends, fees and charges).

Current consensus price target is $128.48, suggesting upside of 49.9% (ex-dividends)

The company's fiscal year ends in March.

Forecast for FY20:

Ord Minnett forecasts a full year FY20 dividend of 530.00 cents and EPS of 796.00 cents.
At the last closing share price the estimated dividend yield is 6.18%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.77.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 825.3, implying annual growth of -6.6%.

Current consensus DPS estimate is 575.7, implying a prospective dividend yield of 6.7%.

Current consensus EPS estimate suggests the PER is 10.4.

Forecast for FY21:

Ord Minnett forecasts a full year FY21 dividend of 460.00 cents and EPS of 698.00 cents.
At the last closing share price the estimated dividend yield is 5.37%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.28.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 800.2, implying annual growth of -3.0%.

Current consensus DPS estimate is 549.8, implying a prospective dividend yield of 6.4%.

Current consensus EPS estimate suggests the PER is 10.7.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

NEC  NINE ENTERTAINMENT CO. HOLDINGS LIMITED

Print, Radio & TV

More Research Tools In Stock Analysis - click HERE

Overnight Price: $1.14

Macquarie rates NEC as Outperform (1) -

The company has announced a number of initiatives in response to the uncertainty generated by the coronavirus crisis.

All up, Macquarie assesses the initiatives are worth $266m by the end of the year, of which just under half relates to savings on NRL broadcast costs.

While advertising momentum has been consistent over the March quarter, the broker suspects this will change going forward and there will be a significant contraction.

Nevertheless, the broker considers the business underpinned by its key digital assets making it better positioned than free-to-air competitors.

Outperform maintained. Target is reduced to $1.60 from $2.05.

Target price is $1.60 Current Price is $1.14 Difference: $0.46
If NEC meets the Macquarie target it will return approximately 40% (excluding dividends, fees and charges).

Current consensus price target is $2.00, suggesting upside of 75.4% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 6.90 cents and EPS of 8.60 cents.
At the last closing share price the estimated dividend yield is 6.05%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.26.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 9.9, implying annual growth of -34.0%.

Current consensus DPS estimate is 6.3, implying a prospective dividend yield of 5.5%.

Current consensus EPS estimate suggests the PER is 11.5.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 6.10 cents and EPS of 10.10 cents.
At the last closing share price the estimated dividend yield is 5.35%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.29.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 10.7, implying annual growth of 8.1%.

Current consensus DPS estimate is 5.7, implying a prospective dividend yield of 5.0%.

Current consensus EPS estimate suggests the PER is 10.7.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


UBS rates NEC as Buy (1) -

The company has announced a number of cost saving measures but also indicated April will be "materially negative". Net debt was just $278m in the first half but UBS expects this to rise to over $400m by the second half.

To manage this debt load, the broker now factors in no second half dividend. Revised forecasts now indicate group operating earnings will decline -5% in FY20 and -8% in FY21.

UBS suspects an advertising market recovery is unlikely to eventuate until the second half of FY21. Buy rating maintained. Target is reduced to $1.70 from $1.85.

Target price is $1.70 Current Price is $1.14 Difference: $0.56
If NEC meets the UBS target it will return approximately 49% (excluding dividends, fees and charges).

Current consensus price target is $2.00, suggesting upside of 75.4% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

UBS forecasts a full year FY20 dividend of 5.00 cents and EPS of 9.00 cents.
At the last closing share price the estimated dividend yield is 4.39%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.67.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 9.9, implying annual growth of -34.0%.

Current consensus DPS estimate is 6.3, implying a prospective dividend yield of 5.5%.

Current consensus EPS estimate suggests the PER is 11.5.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 3.00 cents and EPS of 7.00 cents.
At the last closing share price the estimated dividend yield is 2.63%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.29.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 10.7, implying annual growth of 8.1%.

Current consensus DPS estimate is 5.7, implying a prospective dividend yield of 5.0%.

Current consensus EPS estimate suggests the PER is 10.7.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

NHF  NIB HOLDINGS LIMITED

Insurance

More Research Tools In Stock Analysis - click HERE

Overnight Price: $5.12

Morgans rates NHF as Hold (3) -

Both Medibank Private and nib Holdings have announced they will suspend their approved 2020 premium rate increases for six months. Both will see large claims reductions, the broker notes, as elective surgery and a raft of other non-essential services are put on hold.

In terms of virus-related claims, Medibank has said these claims will be returned to customers while nib is looking forward to a resultant uplift to margins.

The broker has cut forecast earnings and lowered its nib target to $4.94 from $5.35. Hold retained, as while both insurers are relatively positioned better opportunities lie elsewhere in the sector, suggests the broker.

Target price is $4.94 Current Price is $5.12 Difference: minus $0.18 (current price is over target).
If NHF meets the Morgans target it will return approximately minus 4% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $4.98, suggesting downside of -2.8% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Morgans forecasts a full year FY20 dividend of 18.30 cents and EPS of 23.40 cents.
At the last closing share price the estimated dividend yield is 3.57%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.88.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 26.1, implying annual growth of -20.7%.

Current consensus DPS estimate is 22.0, implying a prospective dividend yield of 4.3%.

Current consensus EPS estimate suggests the PER is 19.6.

Forecast for FY21:

Morgans forecasts a full year FY21 dividend of 18.30 cents and EPS of 26.70 cents.
At the last closing share price the estimated dividend yield is 3.57%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.18.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 28.5, implying annual growth of 9.2%.

Current consensus DPS estimate is 24.4, implying a prospective dividend yield of 4.8%.

Current consensus EPS estimate suggests the PER is 18.0.

Market Sentiment: 0.2

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

NXT  NEXTDC LIMITED

Cloud services

More Research Tools In Stock Analysis - click HERE

Overnight Price: $8.90

Morgan Stanley rates NXT as Overweight (1) -

Morgan Stanley assesses NextDC is the best performing stock under coverage. The business is supported by demand within specific communications and business collaboration applications.

The broker suspects the magnitude of the change in behaviour is still under-appreciated by investors, as there has been a large spike in Azure services in affected regions along with remote working.

Overweight maintained. In-Line industry view. Target is $9.00.

Target price is $9.00 Current Price is $8.90 Difference: $0.1
If NXT meets the Morgan Stanley target it will return approximately 1% (excluding dividends, fees and charges).

Current consensus price target is $8.91, suggesting upside of 0.1% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Morgan Stanley forecasts a full year FY20 dividend of 0.00 cents and EPS of minus 5.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 178.00.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -4.5, implying annual growth of N/A.

Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.

Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY21:

Morgan Stanley forecasts a full year FY21 dividend of 0.00 cents and EPS of minus 6.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 148.33.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -3.0, implying annual growth of N/A.

Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.

Current consensus EPS estimate suggests the PER is N/A.

Market Sentiment: 0.8

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

OZL  OZ MINERALS LIMITED

Copper

More Research Tools In Stock Analysis - click HERE

Overnight Price: $7.28

Macquarie rates OZL as Outperform (1) -

The company has reiterated 2020 production guidance. With around 85% of employees based in South Australia, the impact of travel restrictions appears minimal. Expenditure has been cut by -$150m for 2020.

Macquarie is encouraged by the ramp up at Carrapateena, which appears to be running ahead of schedule. Outperform rating maintained. Target is lowered to $10.80 from $11.20.

Target price is $10.80 Current Price is $7.28 Difference: $3.52
If OZL meets the Macquarie target it will return approximately 48% (excluding dividends, fees and charges).

Current consensus price target is $10.36, suggesting upside of 42.4% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 20.00 cents and EPS of 62.50 cents.
At the last closing share price the estimated dividend yield is 2.75%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.65.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 25.7, implying annual growth of -49.3%.

Current consensus DPS estimate is 15.3, implying a prospective dividend yield of 2.1%.

Current consensus EPS estimate suggests the PER is 28.3.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 20.00 cents and EPS of 125.90 cents.
At the last closing share price the estimated dividend yield is 2.75%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 5.78.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 80.3, implying annual growth of 212.5%.

Current consensus DPS estimate is 21.9, implying a prospective dividend yield of 3.0%.

Current consensus EPS estimate suggests the PER is 9.1.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Morgan Stanley rates OZL as Overweight (1) -

The company has maintained 2020 production guidance although has deferred $150m in 2020 expenditure.

Morgan Stanley believes the lower costs and the deferment of expenditure should be viewed positively.

Target is $10. Overweight retained. Industry view: In Line.

Target price is $10.00 Current Price is $7.28 Difference: $2.72
If OZL meets the Morgan Stanley target it will return approximately 37% (excluding dividends, fees and charges).

Current consensus price target is $10.36, suggesting upside of 42.4% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

Morgan Stanley forecasts a full year FY20 dividend of 19.00 cents and EPS of 8.00 cents.
At the last closing share price the estimated dividend yield is 2.61%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 91.00.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 25.7, implying annual growth of -49.3%.

Current consensus DPS estimate is 15.3, implying a prospective dividend yield of 2.1%.

Current consensus EPS estimate suggests the PER is 28.3.

Forecast for FY21:

Morgan Stanley forecasts a full year FY21 dividend of 30.00 cents and EPS of 69.00 cents.
At the last closing share price the estimated dividend yield is 4.12%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.55.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 80.3, implying annual growth of 212.5%.

Current consensus DPS estimate is 21.9, implying a prospective dividend yield of 3.0%.

Current consensus EPS estimate suggests the PER is 9.1.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


UBS rates OZL as Buy (1) -

The company has reiterated 2020 production guidance. More than 85% of the Australian workforce lives in South Australia and the changes to rostering are ensuring there is limited impact on production to date.

Nevertheless, management has reduced discretionary expenditure by -$150m. UBS suspects these cuts to expenditure may delay the potential benefits from the growth options in the portfolio.

However, this is not factored into valuations. A Buy rating is maintained. Target is reduced to $10.90 from $11.00.

Target price is $10.90 Current Price is $7.28 Difference: $3.62
If OZL meets the UBS target it will return approximately 50% (excluding dividends, fees and charges).

Current consensus price target is $10.36, suggesting upside of 42.4% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

UBS forecasts a full year FY20 dividend of 0.00 cents and EPS of minus 6.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 121.33.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 25.7, implying annual growth of -49.3%.

Current consensus DPS estimate is 15.3, implying a prospective dividend yield of 2.1%.

Current consensus EPS estimate suggests the PER is 28.3.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 23.00 cents and EPS of 45.00 cents.
At the last closing share price the estimated dividend yield is 3.16%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.18.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 80.3, implying annual growth of 212.5%.

Current consensus DPS estimate is 21.9, implying a prospective dividend yield of 3.0%.

Current consensus EPS estimate suggests the PER is 9.1.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PDL  PENDAL GROUP LIMITED

Wealth Management & Investments

More Research Tools In Stock Analysis - click HERE

Overnight Price: $4.40

Morgans rates PDL as Hold (3) -

The broker has marked to current equity market valuations for Pendal Group. While Pendal is the cheapest of the listed fund managers, trading well below historical multiples, the broker would prefer to see improvement in relative performance for some UK funds.

The broker has not yet made recommendation changes ahead of the potential for more volatility. Target falls to $5.81 from $8.83, Hold retained.

Target price is $5.81 Current Price is $4.40 Difference: $1.41
If PDL meets the Morgans target it will return approximately 32% (excluding dividends, fees and charges).

Current consensus price target is $7.07, suggesting upside of 60.7% (ex-dividends)

The company's fiscal year ends in September.

Forecast for FY20:

Morgans forecasts a full year FY20 dividend of 30.00 cents and EPS of 41.80 cents.
At the last closing share price the estimated dividend yield is 6.82%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.53.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 47.6, implying annual growth of -12.5%.

Current consensus DPS estimate is 38.5, implying a prospective dividend yield of 8.8%.

Current consensus EPS estimate suggests the PER is 9.2.

Forecast for FY21:

Morgans forecasts a full year FY21 dividend of 30.00 cents and EPS of 40.40 cents.
At the last closing share price the estimated dividend yield is 6.82%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.89.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 49.1, implying annual growth of 3.2%.

Current consensus DPS estimate is 40.5, implying a prospective dividend yield of 9.2%.

Current consensus EPS estimate suggests the PER is 9.0.

Market Sentiment: 0.2

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PNI  PINNACLE INVESTMENT MANAGEMENT GROUP LIMITED

Wealth Management & Investments

More Research Tools In Stock Analysis - click HERE

Overnight Price: $2.86

Morgans rates PNI as Add (1) -

The broker has marked to current equity market valuations for Pinnacle Investment Management.

The broker has not yet made recommendation changes ahead of the potential for more volatility. Target falls to $4.03 from $5.96, Add retained.

Target price is $4.03 Current Price is $2.86 Difference: $1.17
If PNI meets the Morgans target it will return approximately 41% (excluding dividends, fees and charges).

Current consensus price target is $4.14, suggesting upside of 44.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Morgans forecasts a full year FY20 dividend of 12.00 cents and EPS of 14.00 cents.
At the last closing share price the estimated dividend yield is 4.20%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.43.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 13.7, implying annual growth of -25.1%.

Current consensus DPS estimate is 14.3, implying a prospective dividend yield of 5.0%.

Current consensus EPS estimate suggests the PER is 20.9.

Forecast for FY21:

Morgans forecasts a full year FY21 dividend of 12.00 cents and EPS of 14.00 cents.
At the last closing share price the estimated dividend yield is 4.20%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.43.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 11.2, implying annual growth of -18.2%.

Current consensus DPS estimate is 14.2, implying a prospective dividend yield of 5.0%.

Current consensus EPS estimate suggests the PER is 25.5.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PRU  PERSEUS MINING LIMITED

Gold & Silver

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.92

Macquarie rates PRU as Outperform (1) -

The company has updated on the life-of-mine plan at Edikan. Incorporating the plan reduces Macquarie's production estimates for FY21 and FY22 while FY23-25 estimates are lifted.

The broker now expects Edikan production will peak near 270,000 ounces in FY24. A meaningful reduction in costs over the end half of the mine life is expected. Outperform maintained. Target is raised to $1.30 from $1.20.

Target price is $1.30 Current Price is $0.92 Difference: $0.38
If PRU meets the Macquarie target it will return approximately 41% (excluding dividends, fees and charges).

Current consensus price target is $1.10, suggesting upside of 19.2% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 0.00 cents and EPS of 4.90 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.78.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 4.8, implying annual growth of 627.3%.

Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.

Current consensus EPS estimate suggests the PER is 19.2.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 0.00 cents and EPS of 6.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.15.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 6.7, implying annual growth of 39.6%.

Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.

Current consensus EPS estimate suggests the PER is 13.7.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

QBE  QBE INSURANCE GROUP LIMITED

Insurance

More Research Tools In Stock Analysis - click HERE

Overnight Price: $8.46

Morgan Stanley rates QBE as Overweight (1) -

QBE Insurance has withdrawn FY20 guidance for the combined operating ratio and net investment return. A further update will be delivered at the May 7 AGM. The company has indicated capital and liquidity are strong.

Morgan Stanley still expects a negative one-off impact of -15-20% on net profit from current equity markets and wider credit spreads.

While the company reports the premium rate momentum is strong, a softer economy is expected to present a challenge in maintaining rate increases at current levels.

Overweight rating maintained. Target is $15.50. Industry view is In-Line.

Target price is $15.50 Current Price is $8.46 Difference: $7.04
If QBE meets the Morgan Stanley target it will return approximately 83% (excluding dividends, fees and charges).

Current consensus price target is $14.28, suggesting upside of 68.7% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

Morgan Stanley forecasts a full year FY20 dividend of 89.36 cents and EPS of 98.15 cents.
At the last closing share price the estimated dividend yield is 10.56%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.62.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 88.7, implying annual growth of N/A.

Current consensus DPS estimate is 80.6, implying a prospective dividend yield of 9.5%.

Current consensus EPS estimate suggests the PER is 9.5.

Forecast for FY21:

Morgan Stanley forecasts a full year FY21 dividend of 105.48 cents and EPS of 121.59 cents.
At the last closing share price the estimated dividend yield is 12.47%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 6.96.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 115.3, implying annual growth of 30.0%.

Current consensus DPS estimate is 105.9, implying a prospective dividend yield of 12.5%.

Current consensus EPS estimate suggests the PER is 7.3.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.8

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

RAP  RESAPP HEALTH LIMITED

Medical Equipment & Devices

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.19

Morgans rates RAP as Upgrade to Spec Buy from Hold (1) -

ResApp Health has announced it has completed initial integration with its first major commercial partner, Coviu, and signed binding commercial terms for the non-exclusive two-year license for the technology, which Morgans sees as a significant step.

The broker has reduced its discount to valuation due to a view that the recently announced Medicare rebate for telehealth consultations will likely drive increased demand for remote diagnostics.

Target rises to 24c from 8.6c. Rating upgraded to Speculative Buy from Hold.

Target price is $0.24 Current Price is $0.19 Difference: $0.05
If RAP meets the Morgans target it will return approximately 26% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY20:

Morgans forecasts a full year FY20 dividend of 0.00 cents and EPS of minus 0.90 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 21.11.

Forecast for FY21:

Morgans forecasts a full year FY21 dividend of 0.00 cents and EPS of 0.00 cents.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

RSG  RESOLUTE MINING LIMITED

Gold & Silver

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.81

Macquarie rates RSG as Outperform (1) -

Audited 2019 accounts revealed the loss was larger than the preliminary results indicated. Macquarie points out the main variance was a disputed $58m tax expense and provision in relation to claims from the Mali tax authority.

The continued ramp up of Syama sulphides remains critical for de-leveraging, the broker suggests, given expectations of a softer performance from the oxide operation.

Importantly, the company has executed a US$300m facility to refinance the US$63m project loan facility secured against the Mako mine as well as US$195m in senior bank debt. Outperform maintained. Target is $1.

Target price is $1.00 Current Price is $0.81 Difference: $0.19
If RSG meets the Macquarie target it will return approximately 23% (excluding dividends, fees and charges).

The company's fiscal year ends in December.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 0.00 cents and EPS of 26.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 3.05.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 0.00 cents and EPS of 27.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 2.98.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

SCG  SCENTRE GROUP

REITs

More Research Tools In Stock Analysis - click HERE

Overnight Price: $1.56

UBS rates SCG as Upgrade to Neutral from Sell (3) -

The viability of retail tenant businesses is being undermined worldwide. Longer-term, UBS anticipates a re-basing of specialty retail rents -20% lower.

In the current period of uncertainty, the broker expects Scentre Group will resort to capital preservation to ensure a flexible balance sheet.

While gearing is elevated, the broker believes the capital position is sound. To preserve long-term gearing UBS lowers distribution forecasts by -35%.

Rating is upgraded to Neutral from Sell as the current share price implies a -40% decline in asset prices. Target is reduced to $1.53 from $3.70.

Target price is $1.53 Current Price is $1.56 Difference: minus $0.03 (current price is over target).
If SCG meets the UBS target it will return approximately minus 2% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $2.74, suggesting upside of 75.4% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

UBS forecasts a full year FY20 dividend of 6.30 cents and EPS of 18.20 cents.
At the last closing share price the estimated dividend yield is 4.04%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.57.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 22.6, implying annual growth of 1.3%.

Current consensus DPS estimate is 19.2, implying a prospective dividend yield of 12.3%.

Current consensus EPS estimate suggests the PER is 6.9.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 16.10 cents and EPS of 23.10 cents.
At the last closing share price the estimated dividend yield is 10.32%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 6.75.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 25.4, implying annual growth of 12.4%.

Current consensus DPS estimate is 21.9, implying a prospective dividend yield of 14.0%.

Current consensus EPS estimate suggests the PER is 6.1.

Market Sentiment: -0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

SGF  SG FLEET GROUP LIMITED

Vehicle Leasing & Salary Packaging

More Research Tools In Stock Analysis - click HERE

Overnight Price: $1.20

Macquarie rates SGF as Downgrade to Neutral from Outperform (3) -

The company has withdrawn guidance. Macquarie reassesses earnings estimates and adjusts for the anticipated economic impacts. Upfront and end-of-life lease fees are considered the major drivers of reduced earnings.

Working capital risk also increases because of the potential for delayed credit collection, asset value risk and reduced revenue. Rating is downgraded to Neutral from Outperform and the target lowered to $1.85 from $2.60.

Target price is $1.85 Current Price is $1.20 Difference: $0.65
If SGF meets the Macquarie target it will return approximately 54% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 9.80 cents and EPS of 15.00 cents.
At the last closing share price the estimated dividend yield is 8.17%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.00.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 11.50 cents and EPS of 17.60 cents.
At the last closing share price the estimated dividend yield is 9.58%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 6.82.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

SGR  THE STAR ENTERTAINMENT GROUP LIMITED

Gaming

More Research Tools In Stock Analysis - click HERE

Overnight Price: $2.14

UBS rates SGR as Upgrade to Buy from Neutral (1) -

UBS assumes debt covenants will be relaxed by lenders over the next year. The broker also assumes the company will undertake a range of measures to ensure gearing remains under 3x thereafter.

These include a deferral of dividends, a -15% reduction in labour costs and a slowdown in construction at Queens Wharf as well as deferral of the second Gold Coast tower.

The broker upgrades to Buy from Neutral on the basis the value is backed by hard assets with long-dated casino licenses that are currently being discounted by over -50% versus historical averages. Target is to reduce to $3.00 from $4.40.

Target price is $3.00 Current Price is $2.14 Difference: $0.86
If SGR meets the UBS target it will return approximately 40% (excluding dividends, fees and charges).

Current consensus price target is $3.38, suggesting upside of 57.7% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

UBS forecasts a full year FY20 dividend of 11.00 cents and EPS of 7.00 cents.
At the last closing share price the estimated dividend yield is 5.14%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 30.57.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 14.4, implying annual growth of -33.3%.

Current consensus DPS estimate is 15.3, implying a prospective dividend yield of 7.1%.

Current consensus EPS estimate suggests the PER is 14.9.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 0.00 cents and EPS of 8.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 26.75.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 16.4, implying annual growth of 13.9%.

Current consensus DPS estimate is 15.5, implying a prospective dividend yield of 7.2%.

Current consensus EPS estimate suggests the PER is 13.0.

Market Sentiment: 0.9

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

TAH  TABCORP HOLDINGS LIMITED

Gaming

More Research Tools In Stock Analysis - click HERE

Overnight Price: $2.51

Macquarie rates TAH as Outperform (1) -

Macquarie assesses liquidity leverage seems manageable on a six-month shut-down basis. Wagering and lotteries are expected to experience a material step-up in digital volume.

Macquarie envisages longer-term break-up appeal in the stock, supporting a positive view at the current share price. Target is reduced to $4.00 from $4.75.

Target price is $4.00 Current Price is $2.51 Difference: $1.49
If TAH meets the Macquarie target it will return approximately 59% (excluding dividends, fees and charges).

Current consensus price target is $3.78, suggesting upside of 50.4% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 11.00 cents and EPS of 11.30 cents.
At the last closing share price the estimated dividend yield is 4.38%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 22.21.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 16.6, implying annual growth of -7.8%.

Current consensus DPS estimate is 17.5, implying a prospective dividend yield of 7.0%.

Current consensus EPS estimate suggests the PER is 15.1.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 0.00 cents and EPS of 11.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 22.82.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 16.8, implying annual growth of 1.2%.

Current consensus DPS estimate is 13.1, implying a prospective dividend yield of 5.2%.

Current consensus EPS estimate suggests the PER is 14.9.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

TYR  TYRO PAYMENTS LIMITED

Business & Consumer Credit

More Research Tools In Stock Analysis - click HERE

Overnight Price: $1.88

Morgan Stanley rates TYR as Overweight (1) -

Tyro Payments has officially withdrawn its prospectus guidance for FY20. Morgan Stanley is not surprised and had already factored this into estimates. The main issue now is the depth and duration of the contraction.

The broker expects transaction value reductions will worsen before they get better but remains positive on the stock on a 12-month view.

The company has indicated for the month of March total transaction value (TTV) processed for customers was up 11% with 2020 to date up 27%. The broker calculates this implies that in the last seven days TTV fell -15%.

Overweight rating and $3.60 target. Industry view is Attractive.

Target price is $3.60 Current Price is $1.88 Difference: $1.72
If TYR meets the Morgan Stanley target it will return approximately 91% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY20:

Morgan Stanley forecasts a full year FY20 dividend of 0.00 cents and EPS of minus 4.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 47.00.

Forecast for FY21:

Morgan Stanley forecasts a full year FY21 dividend of 0.00 cents and EPS of minus 4.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 47.00.

Market Sentiment: 0.8

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Ord Minnett rates TYR as Accumulate (2) -

Tyro Payments has withdrawn FY20 prospectus financials given the deterioration in trading over the past week.

There has been a sharp deceleration in transaction volumes, attributed to the escalation of social distancing measures in Australia.

Ord Minnett expects continued pressure on short-term trading but notes the business remains well capitalised. Accumulate rating and $2.90 target maintained.

Target price is $2.90 Current Price is $1.88 Difference: $1.02
If TYR meets the Ord Minnett target it will return approximately 54% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY20:

Ord Minnett forecasts a full year FY20 EPS of minus 6.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 31.33.

Forecast for FY21:

Ord Minnett forecasts a full year FY21 EPS of minus 5.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 37.60.

Market Sentiment: 0.8

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

WES  WESFARMERS LIMITED

Apparel & Footwear

More Research Tools In Stock Analysis - click HERE

Overnight Price: $33.96

Credit Suisse rates WES as Neutral (3) -

Wesfarmers intends to sell a 5.2% interest in Coles ((COL)). Credit Suisse suspects investors will speculate about an acquisition but notes Wesfarmers has considerable financial obligations and building a cash flow buffer is the more likely rationale.

One issue facing all retailers where demand has been significantly reduced is creditor payments.

Using the first half balance as an indication, Credit Suisse calculates the potential cash outflow associated with creditors and employee entitlements is in excess of -$5bn.

Operating earnings in the second half would fall significantly if retail closures were in force for a period of time.

While Wesfarmers has not stated this is the issue, the broker is simply making a point that cash can dry up very quickly. Neutral rating and $30.07 target maintained.

Target price is $30.07 Current Price is $33.96 Difference: minus $3.89 (current price is over target).
If WES meets the Credit Suisse target it will return approximately minus 11% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $35.02, suggesting upside of 3.1% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Credit Suisse forecasts a full year FY20 dividend of 136.00 cents and EPS of 167.00 cents.
At the last closing share price the estimated dividend yield is 4.00%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.34.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 160.6, implying annual growth of -6.1%.

Current consensus DPS estimate is 147.4, implying a prospective dividend yield of 4.3%.

Current consensus EPS estimate suggests the PER is 21.1.

Forecast for FY21:

Credit Suisse forecasts a full year FY21 dividend of 156.00 cents and EPS of 173.00 cents.
At the last closing share price the estimated dividend yield is 4.59%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.63.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 165.5, implying annual growth of 3.1%.

Current consensus DPS estimate is 152.0, implying a prospective dividend yield of 4.5%.

Current consensus EPS estimate suggests the PER is 20.5.

Market Sentiment: -0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Morgan Stanley rates WES as Equal-weight (3) -

Wesfarmers intends to sell 5.2% of Coles ((COL)). Morgan Stanley calculates, at the last closing price, the sale would generate pre-tax proceeds of around $1.1bn.

This would be on top of the similar amount of proceeds from the first sell-down in February. The company has highlighted the importance of maintaining a flexible balance sheet in current economic circumstances.

Wesfarmers will retain its remaining share, around 5%, for at least 60 days from completion of the sale and will no longer have the right to nominate a director to the Coles ((COL)) board.

Morgan Stanley retains an Equal-weight rating and $41.50 target. Cautious industry view.

Target price is $41.50 Current Price is $33.96 Difference: $7.54
If WES meets the Morgan Stanley target it will return approximately 22% (excluding dividends, fees and charges).

Current consensus price target is $35.02, suggesting upside of 3.1% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Morgan Stanley forecasts a full year FY20 dividend of 151.00 cents and EPS of 137.00 cents.
At the last closing share price the estimated dividend yield is 4.45%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 24.79.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 160.6, implying annual growth of -6.1%.

Current consensus DPS estimate is 147.4, implying a prospective dividend yield of 4.3%.

Current consensus EPS estimate suggests the PER is 21.1.

Forecast for FY21:

Morgan Stanley forecasts a full year FY21 dividend of 152.00 cents and EPS of 144.00 cents.
At the last closing share price the estimated dividend yield is 4.48%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 23.58.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 165.5, implying annual growth of 3.1%.

Current consensus DPS estimate is 152.0, implying a prospective dividend yield of 4.5%.

Current consensus EPS estimate suggests the PER is 20.5.

Market Sentiment: -0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Ord Minnett rates WES as Lighten (4) -

Wesfarmers has announced a sale of a further 5.2% stake in Coles. Ord Minnett notes already strong liquidity has been strengthened further and suspects the company will divest its entire stake in Coles after the 60-day restriction.

The fall in asset prices also presents the company with an increasing number of opportunities, in the broker's view. The broker maintains a Lighten rating and $31.50 target.

This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.

Target price is $31.50 Current Price is $33.96 Difference: minus $2.46 (current price is over target).
If WES meets the Ord Minnett target it will return approximately minus 7% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $35.02, suggesting upside of 3.1% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY20:

Ord Minnett forecasts a full year FY20 dividend of 141.00 cents and EPS of 165.00 cents.
At the last closing share price the estimated dividend yield is 4.15%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.58.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 160.6, implying annual growth of -6.1%.

Current consensus DPS estimate is 147.4, implying a prospective dividend yield of 4.3%.

Current consensus EPS estimate suggests the PER is 21.1.

Forecast for FY21:

Ord Minnett forecasts a full year FY21 dividend of 149.00 cents and EPS of 161.00 cents.
At the last closing share price the estimated dividend yield is 4.39%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.09.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 165.5, implying annual growth of 3.1%.

Current consensus DPS estimate is 152.0, implying a prospective dividend yield of 4.5%.

Current consensus EPS estimate suggests the PER is 20.5.

Market Sentiment: -0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

WPL  WOODSIDE PETROLEUM LIMITED

NatGas

More Research Tools In Stock Analysis - click HERE

Overnight Price: $18.07

UBS rates WPL as Upgrade to Buy from Neutral (1) -

UBS cuts oil price forecasts by -15-30% for the next five years. Brent is now expected to remain below US$60/bbl until 2024. This will mean a material impact on earnings.

The broker lowers assumptions for oil stocks to reflect the value of the base business, as investors are not expected to pay for growth in this environment.

Woodside Petroleum is upgraded to Buy from Neutral as it is trading at a -21% discount to valuation and has the strongest balance sheet. Target is reduced to $22.60 from $34.60.

Target price is $22.60 Current Price is $18.07 Difference: $4.53
If WPL meets the UBS target it will return approximately 25% (excluding dividends, fees and charges).

Current consensus price target is $24.68, suggesting upside of 36.6% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

UBS forecasts a full year FY20 dividend of 60.06 cents and EPS of 75.89 cents.
At the last closing share price the estimated dividend yield is 3.32%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 23.81.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 82.3, implying annual growth of N/A.

Current consensus DPS estimate is 51.9, implying a prospective dividend yield of 2.9%.

Current consensus EPS estimate suggests the PER is 22.0.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 49.81 cents and EPS of 62.70 cents.
At the last closing share price the estimated dividend yield is 2.76%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 28.82.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 88.7, implying annual growth of 7.8%.

Current consensus DPS estimate is 81.1, implying a prospective dividend yield of 4.5%.

Current consensus EPS estimate suggests the PER is 20.4.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.7

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Today's Price Target Changes
Company Last Price Broker New Target Prev Target Change
ADH ADAIRS $0.91 Morgans 1.22 1.60 -23.75%
AGL AGL ENERGY $17.18 Credit Suisse 14.80 15.30 -3.27%
AHY ASALEO CARE $1.01 Macquarie 1.02 1.16 -12.07%
ANN ANSELL $27.16 Citi 34.50 32.00 7.81%
ANZ ANZ BANKING GROUP $16.67 Morgan Stanley 18.20 19.50 -6.67%
ASG AUTOSPORTS GROUP $0.76 Macquarie 1.10 1.75 -37.14%
AUB AUB GROUP $9.61 Credit Suisse 12.60 13.15 -4.18%
Macquarie 11.71 13.09 -10.54%
BAP BAPCOR LIMITED $4.08 UBS 6.95 7.70 -9.74%
BHP BHP $28.64 Macquarie 38.00 41.00 -7.32%
BOQ BANK OF QUEENSLAND $4.98 Morgans 5.00 7.60 -34.21%
BXB BRAMBLES $10.50 Morgan Stanley 13.00 12.80 1.56%
CAR CARSALES.COM $11.69 UBS 12.50 15.65 -20.13%
CBA COMMBANK $61.19 Morgan Stanley 57.50 60.00 -4.17%
CGF CHALLENGER $3.99 Credit Suisse 4.25 5.40 -21.30%
Ord Minnett 4.00 4.70 -14.89%
CKF COLLINS FOODS $5.43 Morgans 7.06 11.76 -39.97%
CWN CROWN RESORTS $7.55 UBS 9.15 11.40 -19.74%
FCL FINEOS CORP $2.70 Macquarie 3.48 4.30 -19.07%
FMG FORTESCUE $9.94 Macquarie 13.70 12.40 10.48%
GNX GENEX POWER $0.15 Morgans 0.36 0.26 38.46%
GTN GTN LTD $0.49 Macquarie 0.47 0.74 -36.49%
IVC INVOCARE $10.51 Morgans 12.16 15.87 -23.38%
MFG MAGELLAN FINANCIAL GROUP $43.12 Morgans 45.32 65.60 -30.91%
MGX MOUNT GIBSON IRON $0.68 Macquarie 1.00 1.10 -9.09%
MPL MEDIBANK PRIVATE $2.63 Morgans 2.97 3.11 -4.50%
MQG MACQUARIE GROUP $85.73 Ord Minnett 112.00 132.00 -15.15%
NAB NATIONAL AUSTRALIA BANK $16.31 Morgan Stanley 18.70 19.50 -4.10%
NEC NINE ENTERTAINMENT $1.14 Macquarie 1.60 2.05 -21.95%
UBS 1.70 1.85 -8.11%
NHF NIB HOLDINGS $5.12 Morgans 4.94 5.35 -7.66%
ORG ORIGIN ENERGY $4.33 Credit Suisse 4.50 4.70 -4.26%
OSH OIL SEARCH $2.38 UBS 2.70 7.15 -62.24%
OZL OZ MINERALS $7.28 Morgan Stanley 10.00 10.40 -3.85%
UBS 10.90 11.00 -0.91%
PDL PENDAL GROUP $4.40 Morgans 5.81 8.83 -34.20%
PNI PINNACLE INVESTMENT $2.86 Morgans 4.03 5.96 -32.38%
PRU PERSEUS MINING $0.92 Macquarie 1.30 1.20 8.33%
RAP RESAPP HEALTH $0.19 Morgans 0.24 0.09 179.07%
RSG RESOLUTE MINING $0.81 Macquarie 1.00 0.80 25.00%
SCG SCENTRE GROUP $1.56 UBS 1.53 3.70 -58.65%
SGF SG FLEET $1.20 Macquarie 1.85 2.60 -28.85%
SGR STAR ENTERTAINMENT $2.14 UBS 3.00 4.40 -31.82%
STO SANTOS $3.42 UBS 3.60 8.05 -55.28%
TAH TABCORP HOLDINGS $2.51 Macquarie 4.00 4.75 -15.79%
WBC WESTPAC BANKING $16.31 Morgan Stanley 17.20 18.00 -4.44%
WPL WOODSIDE PETROLEUM $18.07 UBS 22.60 34.60 -34.68%
Summaries
ADH ADAIRS Hold - Morgans Overnight Price $0.91
AHY ASALEO CARE Neutral - Macquarie Overnight Price $1.01
AMC AMCOR Accumulate - Ord Minnett Overnight Price $13.02
ANN ANSELL Upgrade to Buy from Neutral - Citi Overnight Price $27.16
Upgrade to Outperform from Neutral - Credit Suisse Overnight Price $27.16
Overweight - Morgan Stanley Overnight Price $27.16
Upgrade to Hold from Lighten - Ord Minnett Overnight Price $27.16
ASG AUTOSPORTS GROUP Downgrade to Neutral from Outperform - Macquarie Overnight Price $0.76
AUB AUB GROUP Outperform - Credit Suisse Overnight Price $9.61
Outperform - Macquarie Overnight Price $9.61
BAP BAPCOR LIMITED Buy - UBS Overnight Price $4.08
BHP BHP Outperform - Macquarie Overnight Price $28.64
BOQ BANK OF QUEENSLAND Equal-weight - Morgan Stanley Overnight Price $4.98
Hold - Morgans Overnight Price $4.98
Hold - Ord Minnett Overnight Price $4.98
BXB BRAMBLES Upgrade to Overweight from Equal-weight - Morgan Stanley Overnight Price $10.50
CAR CARSALES.COM Neutral - UBS Overnight Price $11.69
CGF CHALLENGER Upgrade to Buy from Neutral - Citi Overnight Price $3.99
Neutral - Credit Suisse Overnight Price $3.99
Equal-weight - Morgan Stanley Overnight Price $3.99
Upgrade to Hold from Sell - Ord Minnett Overnight Price $3.99
Neutral - UBS Overnight Price $3.99
CKF COLLINS FOODS Add - Morgans Overnight Price $5.43
CRN CORONADO GLOBAL RESOURCES Outperform - Credit Suisse Overnight Price $1.13
CWN CROWN RESORTS Upgrade to Buy from Neutral - UBS Overnight Price $7.55
FCL FINEOS CORP Outperform - Macquarie Overnight Price $2.70
FMG FORTESCUE Outperform - Macquarie Overnight Price $9.94
GNX GENEX POWER Add - Morgans Overnight Price $0.15
GTN GTN LTD Neutral - Macquarie Overnight Price $0.49
IAG INSURANCE AUSTRALIA Buy - Citi Overnight Price $6.09
Equal-weight - Morgan Stanley Overnight Price $6.09
Neutral - UBS Overnight Price $6.09
IVC INVOCARE Add - Morgans Overnight Price $10.51
MFG MAGELLAN FINANCIAL GROUP Hold - Morgans Overnight Price $43.12
MGX MOUNT GIBSON IRON Outperform - Macquarie Overnight Price $0.68
MP1 MEGAPORT Add - Morgans Overnight Price $9.67
MPL MEDIBANK PRIVATE Hold - Morgans Overnight Price $2.63
MQG MACQUARIE GROUP Upgrade to Buy from Hold - Ord Minnett Overnight Price $85.73
NEC NINE ENTERTAINMENT Outperform - Macquarie Overnight Price $1.14
Buy - UBS Overnight Price $1.14
NHF NIB HOLDINGS Hold - Morgans Overnight Price $5.12
NXT NEXTDC Overweight - Morgan Stanley Overnight Price $8.90
OZL OZ MINERALS Outperform - Macquarie Overnight Price $7.28
Overweight - Morgan Stanley Overnight Price $7.28
Buy - UBS Overnight Price $7.28
PDL PENDAL GROUP Hold - Morgans Overnight Price $4.40
PNI PINNACLE INVESTMENT Add - Morgans Overnight Price $2.86
PRU PERSEUS MINING Outperform - Macquarie Overnight Price $0.92
QBE QBE INSURANCE Overweight - Morgan Stanley Overnight Price $8.46
RAP RESAPP HEALTH Upgrade to Spec Buy from Hold - Morgans Overnight Price $0.19
RSG RESOLUTE MINING Outperform - Macquarie Overnight Price $0.81
SCG SCENTRE GROUP Upgrade to Neutral from Sell - UBS Overnight Price $1.56
SGF SG FLEET Downgrade to Neutral from Outperform - Macquarie Overnight Price $1.20
SGR STAR ENTERTAINMENT Upgrade to Buy from Neutral - UBS Overnight Price $2.14
TAH TABCORP HOLDINGS Outperform - Macquarie Overnight Price $2.51
TYR TYRO PAYMENTS Overweight - Morgan Stanley Overnight Price $1.88
Accumulate - Ord Minnett Overnight Price $1.88
WES WESFARMERS Neutral - Credit Suisse Overnight Price $33.96
Equal-weight - Morgan Stanley Overnight Price $33.96
Lighten - Ord Minnett Overnight Price $33.96
WPL WOODSIDE PETROLEUM Upgrade to Buy from Neutral - UBS Overnight Price $18.07
RATING SUMMARY
Rating No. Of Recommendations
1. Buy

35

2. Accumulate

2

3. Hold

23

4. Reduce

1

Tuesday 31 March 2020

Access Broker Call Report Archives here

Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface. This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.